Report Detail

Other Global (United States, European Union and China) Plasma Therapeutics Market Research Report 2019-2025

  • RnM3665744
  • |
  • 13 August, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Other

Plasma, pale yellow in color, is the component of the blood.
To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.
In 2019, the market size of Plasma Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Plasma Therapeutics.

This report studies the global market size of Plasma Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Plasma Therapeutics production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Baxter
CSL Behring
Grifols Therapeutics
Octapharma
Abeona Therapeutics
ADMA Biologics
Amag Pharmaceuticals
Antares Pharma
BioDelivery Sciences
Bio Products Laboratory
Biota Pharmaceuticals
Biotest Pharmaceuticals
China Biologic Products

Market Segment by Product Type
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins

Market Segment by Application
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Plasma Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Plasma Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Plasma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Plasma Therapeutics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Human Serum Protein
      • 1.3.3 Plasma-Derived Clotting Factor
      • 1.3.4 Immunoglobulins
      • 1.3.5 High Immunoglobulins
    • 1.4 Market Segment by Application
      • 1.4.1 Global Plasma Therapeutics Market Share by Application (2019-2025)
      • 1.4.2 Research Laboratories And Institutions
      • 1.4.3 Hospitals
      • 1.4.4 Stand-Alone Blood Banks
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Plasma Therapeutics Production Value 2014-2025
      • 2.1.2 Global Plasma Therapeutics Production 2014-2025
      • 2.1.3 Global Plasma Therapeutics Capacity 2014-2025
      • 2.1.4 Global Plasma Therapeutics Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Plasma Therapeutics Market Size CAGR of Key Regions
      • 2.2.2 Global Plasma Therapeutics Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Plasma Therapeutics Capacity by Manufacturers
      • 3.1.2 Global Plasma Therapeutics Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Plasma Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Plasma Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Plasma Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Plasma Therapeutics Price by Manufacturers
    • 3.4 Key Manufacturers Plasma Therapeutics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Plasma Therapeutics Market
    • 3.6 Key Manufacturers Plasma Therapeutics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Human Serum Protein Production and Production Value (2014-2019)
      • 4.1.2 Plasma-Derived Clotting Factor Production and Production Value (2014-2019)
      • 4.1.3 Immunoglobulins Production and Production Value (2014-2019)
      • 4.1.4 High Immunoglobulins Production and Production Value (2014-2019)
    • 4.2 Global Plasma Therapeutics Production Market Share by Type
    • 4.3 Global Plasma Therapeutics Production Value Market Share by Type
    • 4.4 Plasma Therapeutics Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Plasma Therapeutics Consumption by Application

    6 Production by Regions

    • 6.1 Global Plasma Therapeutics Production (History Data) by Regions 2014-2019
    • 6.2 Global Plasma Therapeutics Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Plasma Therapeutics Production Growth Rate 2014-2019
      • 6.3.2 United States Plasma Therapeutics Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Plasma Therapeutics Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Plasma Therapeutics Production Growth Rate 2014-2019
      • 6.4.2 European Union Plasma Therapeutics Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Plasma Therapeutics Import & Export
    • 6.5 China
      • 6.5.1 China Plasma Therapeutics Production Growth Rate 2014-2019
      • 6.5.2 China Plasma Therapeutics Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Plasma Therapeutics Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Plasma Therapeutics Consumption by Regions

    • 7.1 Global Plasma Therapeutics Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Plasma Therapeutics Consumption by Type
      • 7.2.2 United States Plasma Therapeutics Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Plasma Therapeutics Consumption by Type
      • 7.3.2 European Union Plasma Therapeutics Consumption by Application
    • 7.4 China
      • 7.4.1 China Plasma Therapeutics Consumption by Type
      • 7.4.2 China Plasma Therapeutics Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Plasma Therapeutics Consumption by Type
      • 7.5.2 Rest of World Plasma Therapeutics Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Baxter
      • 8.1.1 Baxter Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Plasma Therapeutics
      • 8.1.4 Plasma Therapeutics Product Introduction
      • 8.1.5 Baxter Recent Development
    • 8.2 CSL Behring
      • 8.2.1 CSL Behring Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Plasma Therapeutics
      • 8.2.4 Plasma Therapeutics Product Introduction
      • 8.2.5 CSL Behring Recent Development
    • 8.3 Grifols Therapeutics
      • 8.3.1 Grifols Therapeutics Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Plasma Therapeutics
      • 8.3.4 Plasma Therapeutics Product Introduction
      • 8.3.5 Grifols Therapeutics Recent Development
    • 8.4 Octapharma
      • 8.4.1 Octapharma Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Plasma Therapeutics
      • 8.4.4 Plasma Therapeutics Product Introduction
      • 8.4.5 Octapharma Recent Development
    • 8.5 Abeona Therapeutics
      • 8.5.1 Abeona Therapeutics Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Plasma Therapeutics
      • 8.5.4 Plasma Therapeutics Product Introduction
      • 8.5.5 Abeona Therapeutics Recent Development
    • 8.6 ADMA Biologics
      • 8.6.1 ADMA Biologics Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Plasma Therapeutics
      • 8.6.4 Plasma Therapeutics Product Introduction
      • 8.6.5 ADMA Biologics Recent Development
    • 8.7 Amag Pharmaceuticals
      • 8.7.1 Amag Pharmaceuticals Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Plasma Therapeutics
      • 8.7.4 Plasma Therapeutics Product Introduction
      • 8.7.5 Amag Pharmaceuticals Recent Development
    • 8.8 Antares Pharma
      • 8.8.1 Antares Pharma Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Plasma Therapeutics
      • 8.8.4 Plasma Therapeutics Product Introduction
      • 8.8.5 Antares Pharma Recent Development
    • 8.9 BioDelivery Sciences
      • 8.9.1 BioDelivery Sciences Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Plasma Therapeutics
      • 8.9.4 Plasma Therapeutics Product Introduction
      • 8.9.5 BioDelivery Sciences Recent Development
    • 8.10 Bio Products Laboratory
      • 8.10.1 Bio Products Laboratory Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Plasma Therapeutics
      • 8.10.4 Plasma Therapeutics Product Introduction
      • 8.10.5 Bio Products Laboratory Recent Development
    • 8.11 Biota Pharmaceuticals
    • 8.12 Biotest Pharmaceuticals
    • 8.13 China Biologic Products

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Plasma Therapeutics Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Plasma Therapeutics Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Plasma Therapeutics Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Plasma Therapeutics Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Plasma Therapeutics Production Forecast by Type
      • 9.7.2 Global Plasma Therapeutics Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Plasma Therapeutics Sales Channels
      • 10.2.2 Plasma Therapeutics Distributors
    • 10.3 Plasma Therapeutics Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on PlasmaTherapeutics. Industry analysis & Market Report on PlasmaTherapeutics is a syndicated market report, published as Global (United States, European Union and China) Plasma Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of PlasmaTherapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,063.52
      4,595.28
      6,127.04
      516,206.40
      774,309.60
      1,032,412.80
      274,109.60
      411,164.40
      548,219.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report